{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,5]],"date-time":"2026-08-05T08:53:34Z","timestamp":1785920014086,"version":"3.56.0"},"reference-count":51,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2020,11,1]],"date-time":"2020-11-01T00:00:00Z","timestamp":1604188800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2020,11,1]],"date-time":"2020-11-01T00:00:00Z","timestamp":1604188800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2020,9,8]],"date-time":"2020-09-08T00:00:00Z","timestamp":1599523200000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100011665","name":"Deanship of Scientific Research, King Saud University","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100011665","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100007614","name":"Al Jouf University","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100007614","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","em-consulte.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Biomedicine & Pharmacotherapy"],"published-print":{"date-parts":[[2020,11]]},"DOI":"10.1016\/j.biopha.2020.110736","type":"journal-article","created":{"date-parts":[[2020,9,16]],"date-time":"2020-09-16T20:56:20Z","timestamp":1600289780000},"page":"110736","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":16,"special_numbering":"C","title":["Inhibition of Bruton tyrosine kinase by acalabrutinib dampens lipopolysaccharide\/galactosamine-induced hepatic damage"],"prefix":"10.1016","volume":"131","author":[{"given":"Mohamed E.","family":"Shaker","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hesham A.M.","family":"Gomaa","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Khalid S.","family":"Alharbi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mohammad M.","family":"Al-Sanea","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mohamed E.","family":"El-Mesery","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sara H.","family":"Hazem","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"3","key":"10.1016\/j.biopha.2020.110736_bib0005","doi-asserted-by":"crossref","first-page":"267","DOI":"10.1038\/cmi.2016.3","article-title":"Liver immunology and its role in inflammation and homeostasis","volume":"13","author":"Robinson","year":"2016","journal-title":"Cell. Mol. Immunol."},{"issue":"6917","key":"10.1016\/j.biopha.2020.110736_bib0010","doi-asserted-by":"crossref","first-page":"860","DOI":"10.1038\/nature01322","article-title":"Inflammation and cancer","volume":"420","author":"Coussens","year":"2002","journal-title":"Nature"},{"issue":"6409","key":"10.1016\/j.biopha.2020.110736_bib0015","doi-asserted-by":"crossref","first-page":"226","DOI":"10.1038\/361226a0","article-title":"The gene involved in X-linked agammaglobulinaemia is a member of the src family of protein-tyrosine kinases","volume":"361","author":"Vetrie","year":"1993","journal-title":"Nature"},{"key":"10.1016\/j.biopha.2020.110736_bib0020","doi-asserted-by":"crossref","first-page":"1454","DOI":"10.3389\/fimmu.2017.01454","article-title":"Bruton\u2019s tyrosine kinase: an emerging key player in innate immunity","volume":"8","author":"Weber","year":"2017","journal-title":"Front. Immunol."},{"key":"10.1016\/j.biopha.2020.110736_bib0025","doi-asserted-by":"crossref","first-page":"461","DOI":"10.3389\/fimmu.2014.00461","article-title":"Toll-like receptor signaling pathways","volume":"5","author":"Kawasaki","year":"2014","journal-title":"Front. Immunol."},{"issue":"28","key":"10.1016\/j.biopha.2020.110736_bib0030","doi-asserted-by":"crossref","first-page":"26258","DOI":"10.1074\/jbc.M301484200","article-title":"Bruton\u2019s tyrosine kinase is a Toll\/interleukin-1 receptor domain-binding protein that participates in nuclear factor kappaB activation by Toll-like receptor 4","volume":"278","author":"Jefferies","year":"2003","journal-title":"J. Biol. Chem."},{"issue":"6","key":"10.1016\/j.biopha.2020.110736_bib0035","doi-asserted-by":"crossref","DOI":"10.1016\/j.jaci.2013.12.1085","article-title":"Bruton tyrosine kinase mediates TLR9-dependent human dendritic cell activation","volume":"133","author":"Lougaris","year":"2014","journal-title":"J. Allergy Clin. Immunol."},{"issue":"1","key":"10.1016\/j.biopha.2020.110736_bib0040","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0085834","article-title":"Btk regulates macrophage polarization in response to lipopolysaccharide","volume":"9","author":"Ni Gabhann","year":"2014","journal-title":"PLoS One"},{"key":"10.1016\/j.biopha.2020.110736_bib0045","doi-asserted-by":"crossref","first-page":"59","DOI":"10.1186\/1756-8722-6-59","article-title":"Ibrutinib and novel BTK inhibitors in clinical development","volume":"6","author":"Akinleye","year":"2013","journal-title":"J. Hematol. Oncol."},{"issue":"1","key":"10.1016\/j.biopha.2020.110736_bib0050","doi-asserted-by":"crossref","first-page":"32","DOI":"10.1056\/NEJMoa1215637","article-title":"Targeting BTK with ibrutinib in relapsed chronic lymphocytic leukemia","volume":"369","author":"Byrd","year":"2013","journal-title":"N. Engl. J. Med."},{"issue":"12","key":"10.1016\/j.biopha.2020.110736_bib0055","doi-asserted-by":"crossref","first-page":"2097","DOI":"10.3324\/haematol.2018.193391","article-title":"Inhibition of Btk by Btk-specific concentrations of ibrutinib and acalabrutinib delays but does not block platelet aggregation to GPVI","volume":"103","author":"Nicolson","year":"2018","journal-title":"Haematologica"},{"issue":"4","key":"10.1016\/j.biopha.2020.110736_bib0060","doi-asserted-by":"crossref","first-page":"323","DOI":"10.1056\/NEJMoa1509981","article-title":"Acalabrutinib (ACP-196) in relapsed chronic lymphocytic leukemia","volume":"374","author":"Byrd","year":"2016","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.biopha.2020.110736_bib0065","doi-asserted-by":"crossref","first-page":"21","DOI":"10.1186\/s13045-016-0250-9","article-title":"Acalabrutinib (ACP-196): a selective second-generation BTK inhibitor","volume":"9","author":"Wu","year":"2016","journal-title":"J. Hematol. Oncol."},{"issue":"14","key":"10.1016\/j.biopha.2020.110736_bib0070","doi-asserted-by":"crossref","first-page":"3734","DOI":"10.1158\/1078-0432.CCR-16-1446","article-title":"Comparison of acalabrutinib, a selective bruton tyrosine kinase inhibitor, with ibrutinib in chronic lymphocytic leukemia cells","volume":"23","author":"Patel","year":"2017","journal-title":"Clin. Cancer Res."},{"key":"10.1016\/j.biopha.2020.110736_bib0075","first-page":"166","article-title":"Alleviation of lipopolysaccharide\/d-galactosamine-induced liver injury in leukocyte cell-derived chemotaxin 2 deficient mice","volume":"12","author":"Okumura","year":"2017","journal-title":"Biochem. Biophys. Rep."},{"issue":"3","key":"10.1016\/j.biopha.2020.110736_bib0080","doi-asserted-by":"crossref","first-page":"3887","DOI":"10.18632\/oncotarget.23242","article-title":"Catalpol protects mice against lipopolysaccharide\/D-galactosamine-induced acute liver injury through inhibiting inflammatory and oxidative response","volume":"9","author":"Zhang","year":"2018","journal-title":"Oncotarget"},{"issue":"2","key":"10.1016\/j.biopha.2020.110736_bib0085","doi-asserted-by":"crossref","first-page":"240","DOI":"10.1124\/jpet.117.242909","article-title":"Acalabrutinib (ACP-196): a covalent Bruton tyrosine kinase inhibitor with a differentiated selectivity and in vivo potency profile","volume":"363","author":"Barf","year":"2017","journal-title":"J. Pharmacol. Exp. Ther."},{"key":"10.1016\/j.biopha.2020.110736_bib0090","doi-asserted-by":"crossref","first-page":"248","DOI":"10.1016\/0003-2697(76)90527-3","article-title":"A rapid and sensitive method for the quantitation of microgram quantities of protein utilizing the principle of protein-dye binding","volume":"72","author":"Bradford","year":"1976","journal-title":"Anal. Biochem."},{"key":"10.1016\/j.biopha.2020.110736_bib0095","doi-asserted-by":"crossref","first-page":"86","DOI":"10.1016\/j.taap.2015.11.016","article-title":"Experimental models of hepatotoxicity related to acute liver failure","volume":"290","author":"Maes","year":"2016","journal-title":"Toxicol. Appl. Pharmacol."},{"issue":"4","key":"10.1016\/j.biopha.2020.110736_bib0100","doi-asserted-by":"crossref","first-page":"659","DOI":"10.1007\/s12072-010-9219-x","article-title":"The role of lipopolysaccharide\/toll-like receptor 4 signaling in chronic liver diseases","volume":"4","author":"Soares","year":"2010","journal-title":"Hepatol. Int."},{"issue":"7","key":"10.1016\/j.biopha.2020.110736_bib0105","doi-asserted-by":"crossref","first-page":"1127","DOI":"10.1093\/aob\/mcq243","article-title":"Proliferating cell nuclear antigen (PCNA): a key factor in DNA replication and cell cycle regulation","volume":"107","author":"Strzalka","year":"2011","journal-title":"Ann. Bot."},{"issue":"32","key":"10.1016\/j.biopha.2020.110736_bib0110","doi-asserted-by":"crossref","first-page":"1354","DOI":"10.4254\/wjh.v8.i32.1354","article-title":"Toll-like receptors in pathophysiology of liver diseases","volume":"8","author":"Kiziltas","year":"2016","journal-title":"World J. Hepatol."},{"issue":"12","key":"10.1016\/j.biopha.2020.110736_bib0115","doi-asserted-by":"crossref","first-page":"1012","DOI":"10.1016\/j.tibs.2016.09.002","article-title":"Mechanism and regulation of NLRP3 inflammasome activation","volume":"41","author":"He","year":"2016","journal-title":"Trends Biochem. Sci."},{"issue":"4","key":"10.1016\/j.biopha.2020.110736_bib0120","doi-asserted-by":"crossref","first-page":"1054","DOI":"10.1016\/j.jaci.2017.01.017","article-title":"LRR, and PYD domain-containing protein 3 (NLRP3) inflammasome activity is regulated by and potentially targetable through Bruton tyrosine kinase","volume":"140","author":"Liu","year":"2017","journal-title":"J. Allergy Clin. Immunol."},{"issue":"1","key":"10.1016\/j.biopha.2020.110736_bib0125","doi-asserted-by":"crossref","first-page":"230","DOI":"10.1016\/j.bbrc.2016.12.161","article-title":"The NLRP3 inflammasome and bruton\u2019s tyrosine kinase in platelets co-regulate platelet activation, aggregation, and in vitro thrombus formation","volume":"483","author":"Murthy","year":"2017","journal-title":"Biochem. Biophys. Res. Commun."},{"issue":"1","key":"10.1016\/j.biopha.2020.110736_bib0130","first-page":"119","article-title":"Tumor necrosis factor-\u03b1: life and death of hepatocytes during liver ischemia\/reperfusion injury","volume":"13","author":"Shuh","year":"2013","journal-title":"Ochsner J."},{"issue":"5","key":"10.1016\/j.biopha.2020.110736_bib0135","doi-asserted-by":"crossref","first-page":"777","DOI":"10.1111\/j.1530-0277.2010.01150.x","article-title":"Induction of innate immune gene expression cascades in brain slice cultures by ethanol: key role of NF-kappaB and proinflammatory cytokines","volume":"34","author":"Zou","year":"2010","journal-title":"Alcohol. Clin. Exp. Res."},{"key":"10.1016\/j.biopha.2020.110736_bib0140","doi-asserted-by":"crossref","DOI":"10.1155\/2016\/2148129","article-title":"How does interleukin-22 mediate liver regeneration and prevent injury and fibrosis?","volume":"2016","author":"Khawar","year":"2016","journal-title":"J. Immunol. Res."},{"issue":"4","key":"10.1016\/j.biopha.2020.110736_bib0145","doi-asserted-by":"crossref","first-page":"960","DOI":"10.1038\/leu.2017.304","article-title":"Ibrutinib modulates the immunosuppressive CLL microenvironment through STAT3-mediated suppression of regulatory B-cell function and inhibition of the PD-1\/PD-L1 pathway","volume":"32","author":"Kondo","year":"2018","journal-title":"Leukemia"},{"issue":"10","key":"10.1016\/j.biopha.2020.110736_bib0150","doi-asserted-by":"crossref","DOI":"10.1371\/journal.ppat.1006690","article-title":"Bacillus anthracis lethal toxin negatively modulates ILC3 function through perturbation of IL-23-mediated MAPK signaling","volume":"13","author":"Seshadri","year":"2017","journal-title":"PLoS Pathog."},{"issue":"6","key":"10.1016\/j.biopha.2020.110736_bib0155","doi-asserted-by":"crossref","first-page":"435","DOI":"10.1016\/j.cytogfr.2010.10.007","article-title":"Distinct roles of IL-22 in human psoriasis and inflammatory bowel disease","volume":"21","author":"Ouyang","year":"2010","journal-title":"Cytokine Growth Factor Rev."},{"issue":"7","key":"10.1016\/j.biopha.2020.110736_bib0160","doi-asserted-by":"crossref","first-page":"666","DOI":"10.1038\/s41423-018-0055-6","article-title":"Interleukin-22 from bench to bedside: a promising drug for epithelial repair","volume":"16","author":"Gao","year":"2019","journal-title":"Cell. Mol. Immunol."},{"issue":"4","key":"10.1016\/j.biopha.2020.110736_bib0165","doi-asserted-by":"crossref","first-page":"447","DOI":"10.1016\/j.coph.2009.04.008","article-title":"Anti-inflammatory and pro-inflammatory roles of TGF-beta, IL-10, and IL-22 in immunity and autoimmunity","volume":"9","author":"Sanjabi","year":"2009","journal-title":"Curr. Opin. Pharmacol."},{"key":"10.1016\/j.biopha.2020.110736_bib0170","doi-asserted-by":"crossref","first-page":"21","DOI":"10.1186\/1755-1536-3-21","article-title":"Toll-like receptor 4 signaling in liver injury and hepatic fibrogenesis","volume":"3","author":"Guo","year":"2010","journal-title":"Fibrogenesis Tissue Rep."},{"issue":"11","key":"10.1016\/j.biopha.2020.110736_bib0175","doi-asserted-by":"crossref","first-page":"1270","DOI":"10.1038\/cr.2013.116","article-title":"MicroRNA-124 mediates the cholinergic anti-inflammatory action through inhibiting the production of pro-inflammatory cytokines","volume":"23","author":"Sun","year":"2013","journal-title":"Cell Res."},{"issue":"9","key":"10.1016\/j.biopha.2020.110736_bib0180","doi-asserted-by":"crossref","first-page":"1237","DOI":"10.7150\/ijbs.4989","article-title":"IL-6 trans-signaling via the soluble IL-6 receptor: importance for the pro-inflammatory activities of IL-6","volume":"8","author":"Rose-John","year":"2012","journal-title":"Int. J. Biol. Sci."},{"issue":"11","key":"10.1016\/j.biopha.2020.110736_bib0185","doi-asserted-by":"crossref","first-page":"3517","DOI":"10.4049\/jimmunol.143.11.3517","article-title":"IL-6 inhibits lipopolysaccharide-induced tumor necrosis factor production in cultured human monocytes, U937 cells, and in mice","volume":"143","author":"Aderka","year":"1989","journal-title":"J. Immunol."},{"issue":"1","key":"10.1016\/j.biopha.2020.110736_bib0190","doi-asserted-by":"crossref","first-page":"642","DOI":"10.4049\/jimmunol.177.1.642","article-title":"A regulatory effect of the balance between TNF-alpha and IL-6 in the granulomatous and inflammatory response to Rhodococcus aurantiacus infection in mice","volume":"177","author":"Yimin","year":"2006","journal-title":"J. Immunol."},{"issue":"7","key":"10.1016\/j.biopha.2020.110736_bib0195","doi-asserted-by":"crossref","first-page":"978","DOI":"10.1172\/JCI19974","article-title":"Hepatoprotection via the IL-6\/Stat3 pathway","volume":"112","author":"Taub","year":"2003","journal-title":"J. Clin. Invest."},{"issue":"15","key":"10.1016\/j.biopha.2020.110736_bib0200","doi-asserted-by":"crossref","first-page":"1811","DOI":"10.3748\/wjg.v16.i15.1811","article-title":"Role of monocytes and macrophages in experimental and human acute liver failure","volume":"16","author":"Possamai","year":"2010","journal-title":"World J. Gastroenterol."},{"issue":"6","key":"10.1016\/j.biopha.2020.110736_bib0205","doi-asserted-by":"crossref","first-page":"313","DOI":"10.1089\/jir.2008.0027","article-title":"Monocyte chemoattractant protein-1 (MCP-1): an overview","volume":"29","author":"Deshmane","year":"2009","journal-title":"J. Interferon Cytokine Res."},{"issue":"Suppl 3","key":"10.1016\/j.biopha.2020.110736_bib0210","doi-asserted-by":"crossref","DOI":"10.1186\/cc7811","article-title":"CCR2 expression on neutrophils leads to detrimental tissue infiltration during sepsis","volume":"13","author":"Souto","year":"2009","journal-title":"Crit. Care"},{"issue":"2","key":"10.1016\/j.biopha.2020.110736_bib0215","doi-asserted-by":"crossref","first-page":"234","DOI":"10.1164\/rccm.201003-0416OC","article-title":"Essential role of CCR2 in neutrophil tissue infiltration and multiple organ dysfunction in sepsis","volume":"183","author":"Souto","year":"2011","journal-title":"Am. J. Respir. Crit. Care Med."},{"issue":"2","key":"10.1016\/j.biopha.2020.110736_bib0220","doi-asserted-by":"crossref","first-page":"322","DOI":"10.1097\/TP.0000000000001552","article-title":"Bruton tyrosine kinase inhibition attenuates liver damage in a mouse warm ischemia and reperfusion model","volume":"101","author":"Palumbo","year":"2017","journal-title":"Transplantation"},{"issue":"3","key":"10.1016\/j.biopha.2020.110736_bib0225","doi-asserted-by":"crossref","first-page":"429","DOI":"10.1111\/bph.14090","article-title":"PRN473, an inhibitor of Bruton\u2019s tyrosine kinase, inhibits neutrophil recruitment via inhibition of macrophage antigen-1 signalling","volume":"175","author":"Herter","year":"2018","journal-title":"Br. J. Pharmacol."},{"key":"10.1016\/j.biopha.2020.110736_bib0230","doi-asserted-by":"crossref","first-page":"85","DOI":"10.3389\/fimmu.2019.00085","article-title":"Cell type-specific roles of NF-\u03baB linking inflammation and thrombosis","volume":"10","author":"Mussbacher","year":"2019","journal-title":"Front. Immunol."},{"issue":"11","key":"10.1016\/j.biopha.2020.110736_bib0235","doi-asserted-by":"crossref","first-page":"1696","DOI":"10.1111\/j.1349-7006.2007.00587.x","article-title":"Identification of cell proliferation-associated epitope on CD98 oncoprotein using phage display random peptide library","volume":"98","author":"Itoh","year":"2007","journal-title":"Cancer Sci."},{"issue":"2","key":"10.1016\/j.biopha.2020.110736_bib0240","doi-asserted-by":"crossref","first-page":"188","DOI":"10.1016\/j.dld.2016.11.008","article-title":"CD98 siRNA-loaded nanoparticles decrease hepatic steatosis in mice","volume":"49","author":"Canup","year":"2017","journal-title":"Dig. Liver Dis."},{"key":"10.1016\/j.biopha.2020.110736_bib0245","doi-asserted-by":"crossref","first-page":"54731","DOI":"10.1074\/jbc.M408700200","article-title":"CD98hc (SLC3A2) interaction with beta 1 integrins is required for transformation","volume":"2004","author":"Henderson","year":"2004","journal-title":"J. Biol Chem ."},{"issue":"6","key":"10.1016\/j.biopha.2020.110736_bib0250","doi-asserted-by":"crossref","first-page":"1193","DOI":"10.1016\/j.jhep.2019.07.019","article-title":"Integrin beta1-enriched extracellular vesicles mediate monocyte adhesion and promote liver inflammation in murine NASH","volume":"71","author":"Guo","year":"2019","journal-title":"J. Hepatol."},{"issue":"28","key":"10.1016\/j.biopha.2020.110736_bib0255","doi-asserted-by":"crossref","first-page":"E6467","DOI":"10.1073\/pnas.1722317115","article-title":"Targeting beta1-integrin inhibits vascular leakage in endotoxemia","volume":"115","author":"Hakanpaa","year":"2018","journal-title":"Proc. Natl. Acad. Sci. U. S. A."}],"container-title":["Biomedicine & Pharmacotherapy"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S075333222030929X?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S075333222030929X?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,12,18]],"date-time":"2025-12-18T18:47:46Z","timestamp":1766083666000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S075333222030929X"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,11]]},"references-count":51,"alternative-id":["S075333222030929X"],"URL":"https:\/\/doi.org\/10.1016\/j.biopha.2020.110736","relation":{},"ISSN":["0753-3322"],"issn-type":[{"value":"0753-3322","type":"print"}],"subject":[],"published":{"date-parts":[[2020,11]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Inhibition of Bruton tyrosine kinase by acalabrutinib dampens lipopolysaccharide\/galactosamine-induced hepatic damage","name":"articletitle","label":"Article Title"},{"value":"Biomedicine & Pharmacotherapy","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.biopha.2020.110736","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2020 The Authors. Published by Elsevier Masson SAS.","name":"copyright","label":"Copyright"}],"article-number":"110736"}}